Design of a Factorial Experiment with Randomization Restrictions to Assess Medical Device Performance on Vascular Tissue by Diestelkamp, Wiebke et al.
University of Dayton
eCommons
Biology Faculty Publications Department of Biology
5-2011
Design of a Factorial Experiment with
Randomization Restrictions to Assess Medical
Device Performance on Vascular Tissue
Wiebke Diestelkamp
University of Dayton, wdiestelkamp1@udayton.edu
Carissa M. Krane
University of Dayton, ckrane1@udayton.edu
Margaret Pinnell
University of Dayton, mpinnell1@udayton.edu
Follow this and additional works at: https://ecommons.udayton.edu/bio_fac_pub
Part of the Biology Commons, Biotechnology Commons, Cell Biology Commons, Genetics
Commons, Microbiology Commons, and the Molecular Genetics Commons
This Article is brought to you for free and open access by the Department of Biology at eCommons. It has been accepted for inclusion in Biology
Faculty Publications by an authorized administrator of eCommons. For more information, please contact frice1@udayton.edu,
mschlangen1@udayton.edu.
eCommons Citation
Diestelkamp, Wiebke; Krane, Carissa M.; and Pinnell, Margaret, "Design of a Factorial Experiment with Randomization Restrictions
to Assess Medical Device Performance on Vascular Tissue" (2011). Biology Faculty Publications. 140.
https://ecommons.udayton.edu/bio_fac_pub/140
TECHNICAL ADVANCE Open Access
Design of a factorial experiment with
randomization restrictions to assess medical
device performance on vascular tissue
Wiebke S Diestelkamp1*, Carissa M Krane2* and Margaret F Pinnell3
Abstract
Background: Energy-based surgical scalpels are designed to efficiently transect and seal blood vessels using thermal
energy to promote protein denaturation and coagulation. Assessment and design improvement of ultrasonic scalpel
performance relies on both in vivo and ex vivo testing. The objective of this work was to design and implement a
robust, experimental test matrix with randomization restrictions and predictive statistical power, which allowed for
identification of those experimental variables that may affect the quality of the seal obtained ex vivo.
Methods: The design of the experiment included three factors: temperature (two levels); the type of solution used
to perfuse the artery during transection (three types); and artery type (two types) resulting in a total of twelve
possible treatment combinations. Burst pressures of porcine carotid and renal arteries sealed ex vivo were assigned
as the response variable.
Results: The experimental test matrix was designed and carried out as a split-plot experiment in order to assess
the contributions of several variables and their interactions while accounting for randomization restrictions present
in the experimental setup. The statistical software package SAS was utilized and PROC MIXED was used to account
for the randomization restrictions in the split-plot design. The combination of temperature, solution, and vessel
type had a statistically significant impact on seal quality.
Conclusions: The design and implementation of a split-plot experimental test-matrix provided a mechanism for
addressing the existing technical randomization restrictions of ex vivo ultrasonic scalpel performance testing, while
preserving the ability to examine the potential effects of independent factors or variables. This method for
generating the experimental design and the statistical analyses of the resulting data are adaptable to a wide
variety of experimental problems involving large-scale tissue-based studies of medical or experimental device
efficacy and performance.
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Background
Blood vessel transection and sealing requires that tissue
segments be held together with an immediate and tem-
porary bond that prevents leakage and holds long
enough to allow the adjacent tissue margins to re-grow,
heal, and regenerate structural connections through the
natural healing process. Energy-based vessel sealing
methods use no exogenous materials to accomplish ves-
sel closure, but rely on acute vessel compression, ther-
mally induced tissue injury, and tissue healing to
generate the seal. This process limits inflammation and
eliminates concerns with biocompatibility and immuno-
genicity associated with using an exogenous material
such as sutures, staples, or bonding adhesives. In addi-
tion, energy-based methods are easier and faster to use
than materials-based methods, especially for endoscopic
surgeries, resulting in a decrease in operative time and
surgical invasiveness, and reduced infection rates.
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Ultrasonic scalpel technology has been used extensively
in fine tissue dissection, hemostasis, vessel closure and
transection [1-3]. The optimization of ultrasonic device
performance relies on both in vivo animal testing and
ex vivo tissue testing at a level and degree that achieves
statistically significant evidence of performance stan-
dards. Many physiological and anatomical properties of
biological tissues exhibit inter-individual variability due
to the sex, age, and health of the animal from which
the tissue was harvested. Moreover, it is technically dif-
ficult to recapitulate physiological conditions ex vivo.
However, proof of device efficacy through ex vivo test-
ing is required prior to in vivo testing. As such, it is cri-
tical to control as many experimental variables as
possible, and to measure those that cannot be con-
trolled during ex vivo testing in order to achieve results
that realistically assess device performance. Therefore,
the challenge is to identify those experimental condi-
tions that should be tested, and those that should be
controlled. The generation of statistically relevant obser-
vations is dependent on the careful design of a test
matrix that facilitates the assessment of the effects of
fixed and variable test conditions while taking into
account technical or procedural restrictions to randomi-
zation that exist for the proposed experiments. In this
report, the computational and biostatistical tools that
were employed to generate a robust and randomized
test matrix to assess ex vivo ultrasonic scalpel perfor-
mance are described.
Methods
Porcine vessel sealing and burst pressure test
Porcine vessel sealing and burst pressure testing were
performed as previously described [4]. Briefly, porcine
carotid and renal arteries were harvested from tissue
remnants from animals slaughtered for food consump-
tion at a USDA-inspected slaughterhouse facility by
technicians from Animal Technologies (Tylersville, TX).
Institutional Animal Care and Use Committee (IACUC)
approval was not required for the use of these tissue
remnants since no live animals were used in experi-
ments, and the tissues were obtained from a food-pur-
posed slaughterhouse source. Luer locks were sutured
to each end of the artery. The arteries were mounted
onto a custom-designed tension device that stretched
the vessel at a constant rate of 0.7 mm/s to a load of
~113 gram-force (0.25 lbf). The tensioned vessel was
infused with one of three test solutions pre-equilibrated
to ambient temperature (23°C) or 37°C. An HA2001
PHD2000 Harvard Apparatus dual syringe infusion
pump supplied a constant infusion rate of 1.5 ml/min.
During infusion, each artery was transected and sealed
using an ultrasonic scalpel connected to an ultrasonic
generator set at power level 3. Subsequent to
transection and sealing, each vessel was subjected to
pressure burst testing. A 10,340 mmHg (200 psi) Mea-
surements Specialties MSP-300-200-P-N-1- pressure
transducer was used to record the pressure that was
generated in the sealed vessel during constant infusion
with the test solution at a rate of 20 ml/min. Vessel
burst pressure, the response variable in this experiment,
was defined as the pressure at which the test solution
was observed to leak from the seal and/or a rapid drop
in pressure was noted in the pressure versus time curve
[5,6]. The load cell and pressure transducers were con-
nected to a Vishay Micromeasurements System 5000
Model 5100 B Scanner and Strain Smart® software was
used to record the data.
Biostatistical experimental matrix design
The design included three factors: The temperature of
the solution (Temp - two levels; ambient (23°C) or 37°
C), the type of solution that was utilized (Sol - three
types; 0.9% saline; 6% Hetastarch (HES); “Plasma pro-
tein” enriched buffer (95% Hanks balanced salt solution,
4.7% bovine serum albumin fraction V, 0.36% fibrinogen
type IV)) and the type of vascular tissue used (Vessel -
two types; carotid or renal artery).
Sample size calculation
A number of preliminary experiments (n = 4-12) were
carried out as described above. The data were used to
perform basic sample size computations to aid in deter-
mining the sample size for the main experiment. All
computations were based on comparisons of two means.
To determine the sample size necessary to detect a sig-
nificant difference between the means of two factors at
a desired significance level and with given power, the
observed sample means and the pooled standard devia-
tion corresponding to the two factors from the pilot
were computed. The Analyst application in SAS was uti-
lized to compute the sample sizes. The input consisted
of the two observed sample means, the pooled standard
deviation, the desired significance level and the desired
power for the test.
Statistical analyses of the data
The statistical package SAS was used to carry out the
data analysis. The factors temperature, solution and ves-
sel type, as well as “Session” (with 48 levels) were
declared as class variables for the analysis of variance.
To incorporate the information about the randomization
restrictions discussed above, PROC MIXED was used,
and Session was declared as a random effect as sug-
gested in [7] (the others are treated as fixed effects by
default). The data set was imported into SAS from
Excel, with columns for session, temperature, solution,
vessel type and the response variable.
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SAS code
PROC MIXED data = dataset;
CLASS Session Temp Sol Vessel;
MODEL response = Temp|Sol|Vessel;
RANDOM session;
RUN;
Interpretation of SAS output
SAS computed the ANOVA table displaying the p-
values for the main effects (temperature, solution and
vessel type) and their interactions. Using the significance
level of 0.05, a p-value of less than 0.05 indicates a (sta-
tistically) significant main effect or interaction effect.
Results
The objective of this work was to design and implement
a robust, experimental test matrix with randomization
restrictions and predictive statistical power, which
allowed for identification of those experimental variables
that may affect the quality of the seal obtained ex vivo.
A number of pilot studies using small sample sizes were
initially performed to determine which variables likely
contribute to seal quality and therefore should be
included in the test design. The factors initially studied
included temperature of the solution, type of infusion
solution, vessel type, and infusion flow rate during
blood vessel transection/sealing. The response variable
in each case was the burst pressure (mmHg) at which
the seal failed.
In addition, the pilot data was used to estimate the
sample size needed to obtain significant results (at a sig-
nificance level of 0.05) with a power of 0.9, or the prob-
ability that a test with the specified assumptions (sample
size, observed difference of means, observed pooled
standard deviation, and type of alternative hypothesis)
would correctly reject the null hypothesis when the
alternative hypothesis was true. Given the minimum
desired detectable difference, as well as (an estimation
for) the standard deviation and the desired significance
level of the test, the sample size that was necessary for a
two-sample test to have a given power was computed.
The sample size computations were based on pairwise
comparisons, in which each factor level was examined
as to its potential effect on burst pressure. In some
cases, it was clear that these comparisons were not
trending towards showing significant differences, and
the corresponding factors (or factor levels) were there-
fore not included in the experimental design. However,
those comparisons that were not statistically significant
in the pilot study due to small sample size but showed a
trend toward predicted statistical significant differences
with an increased sample size (based on the power cal-
culation) were included in the experimental design. In
addition, the interaction effects of the included factors
(comparisons between combinations of two or three fac-
tors) were deemed important to assess.
Based on the pilot studies, the effects of solution
temperature, solution type, and vessel type were cho-
sen to be studied. Taking into account the sample size
computations made from the pilot study and the prac-
tical limitations imposed by the experimental test
setup, the size of the matrix and experimental design
was determined. A balanced design for the test matrix
was selected where each treatment combination was
observed the same number of times. The experiment
included three factors, with a total of 12 possible treat-
ment combinations. While the vessel type could be
varied at random from run to run, the temperature
and solution were hard-to-change factors. This physi-
cal reality forced randomization restrictions on the
design. The experiment consisted of 480 runs (40 per
treatment combination), divided into 48 sessions of 10
runs each. For each session, one of the six combina-
tions of levels for temperature and solution was chosen
(each combination was used for eight different ses-
sions) and held fixed. The assignment of the treatment
combinations to the sessions was carried out at ran-
dom. This assignment was done in Excel. Using a col-
umn for temperature and a column for solution, eight
copies of the treatment combinations of temperature
and solution were generated. A third column contained
random numbers. The data in the three columns was
then sorted in ascending order of the random numbers
to create a random order of the treatment combina-
tions. The treatment combinations were then assigned
to the 48 sessions in that order. Each session contained
ten runs (five runs per vessel type) chosen in random
order using the same procedure in Excel. The proce-
dure to generate a random order of the sessions is
shown in Table 1. For simplicity, the procedure is
demonstrated for the case of only 12 sessions, where
each Temperature/Solution combination is used for
two sessions. The random numbers in the third col-
umn were generated using the rand() function (which
generates a random number between 0 and 1). Next,
the three columns were sorted by the size of the ran-
dom numbers (Table 2). This resulted in a random
ordering of the 12 rows (sessions; Table 3). For exam-
ple, in session 1, Temperature 1 and Solution 3 were
used throughout, while in session 2, Temperature 2
and Solution 2 were used for all runs.
An analysis of variance was conducted to determine
the effects of the factors and their interactions. The
resulting ANOVA table is shown in Table 4. For this
data set, there were no significant main effects due to
vessel type, solution temperature, or type of solution,
nor were there significant two-factor interactions (at the
0.05 significance level). Only the 3-factor interaction
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between temperature, solution and vessel type was sig-
nificant at 0.05, with a p-value of 0.027.
Discussion
Assessing the efficacy of surgical device performance ex
vivo is dependent upon the quality of the experimental
design, and the ability of the test to control or measure
those variables that contribute to device performance.
Careful design of the experimental test matrix is an
important first step in this process. Failure to appropri-
ately consider practical limitations on randomization
can substantially compromise the utility and significance
of the data generated. The biostatistical methods
described in this report provide a procedural model for
the development of the design of factorial experiments
that have randomization restrictions. Since the impact
of more than two factors on a response variable were
assessed in this experiment, it was appropriate to carry
out an analysis of variance. However, an underlying
assumption for the validity of the usual analysis of var-
iance for a complete factorial design is that the runs are
observed in a completely randomized order [8]. This
usually requires frequent changes in the levels of the
factors, which proved to be problematic in this experi-
ment. While it was possible to randomly assign one of
the two tissue types to an experimental run, there were
several constraints on the other two factors due to the
setup of the experiment. Solution and temperature were
the hard-to-change factors. Changing the temperature
required considerable time and effort, as the solution,
the tissue and the apparatus needed to be adjusted to
the new temperature. Changing the solution required a
complete disassembly of the apparatus since the entire
apparatus had to be flushed, cleaned and dried before a
different solution could be employed. Due to these con-
straints, a completely random order of the 480 runs was
not feasible. Instead, a split-plot design was used [9]. A
split-plot experiment is a blocked experiment, but the
blocks themselves are experimental units for a subset of
the factors. The blocks are called whole plots, while the
Table 1 Two copies of the six Temperature/Solution
combinations, plus a column of random numbers
Temperature Solution Random number
Temp1 Sol1 0.617940611
Temp1 Sol2 0.739488341
Temp1 Sol3 0.088714721
Temp2 Sol1 0.556090887
Temp2 Sol2 0.55227804
Temp2 Sol3 0.691030612
Temp1 Sol1 0.286876071
Temp1 Sol2 0.535759581
Temp1 Sol3 0.882488882
Temp2 Sol1 0.981425728
Temp2 Sol2 0.228304389
Temp2 Sol3 0.606414609
Table 2 Two copies of the six Temperature/Solution
combinations, ordered by the size of the random
numbers
Temperature Solution Random number
Temp1 Sol3 0.088714721
Temp2 Sol2 0.228304389
Temp1 Sol1 0.286876071
Temp1 Sol2 0.535759581
Temp2 Sol2 0.55227804
Temp2 Sol1 0.556090887
Temp2 Sol3 0.606414609
Temp1 Sol1 0.617940611
Temp2 Sol3 0.691030612
Temp1 Sol2 0.739488341
Temp1 Sol3 0.882488882
Temp2 Sol1 0.981425728
Table 3 The twelve sessions in random order
Session Temperature Solution
1 Temp1 Sol3
2 Temp2 Sol2
3 Temp1 Sol1
4 Temp1 Sol2
5 Temp2 Sol2
6 Temp2 Sol1
7 Temp2 Sol3
8 Temp1 Sol1
9 Temp2 Sol3
10 Temp1 Sol2
11 Temp1 Sol3
12 Temp2 Sol1
Table 4 ANOVA Table
Effect Num DF Den DF F Value Pr > F
Sol 2 426 0.21 0.812
Temp 1 426 1.14 0.2857
Sol*Temp 2 426 0.05 0.949
Vessel 1 426 2.65 0.1045
Sol*Vessel 2 426 0.83 0.4354
Temp*Vessel 1 426 1.36 0.2449
Sol*Temp*Vessel 2 426 3.64 0.027
Num DF = numerator degrees of freedom, Den DF = denominator degrees of
freedom for the corresponding sum of squares. F Value = value of the
corresponding F distribution. Pr > F = p-value.
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experimental units within blocks are split plots. This
introduces two levels of randomization: The random
order of the whole plots, and the random assignment of
the treatments within the whole plots. This approach
has been successfully used in industrial experiments
involving factors that are hard or costly to change
[7,10-13]. In the experiment described here, the whole
plots consisted of the sessions (with solution and tem-
perature fixed in each session), and each type of vessel
was observed five times within each session (in random
order). Using this experimental design and analysis, it
was determined that the combination of temperature,
solution, and vessel type affected seal quality in a statis-
tically significant way. Therefore, experimentally, it is
apparent from these data that all three of these factors
need to be considered when developing an ex vivo test
method for the assessment of harmonic scalpel perfor-
mance and device optimization.
Acute collateral damage, although expected, was not
examined in this study. Histopathology is commonly
used to estimate the extent and degree of thermally-
induced coagulative necrosis and protein denaturation
incurred in relation to the distance from the point of
energy application [14]. However, measurements of tis-
sue injury margins obtained by histopathology may not
reflect the true distance of thermal impact due to the
tissue shrinkage that occurs during processing [15]. Sev-
eral methods exist for determining temperature eleva-
tion and thermal spread in tissues at and at fixed
distances from the energy source [16]. However, differ-
ences exist between in vivo and ex vivo analyses of col-
lateral damage and thermal spread, especially at larger
distances from the blade [17]. These differences are
likely due to the effects of perfusion on the efficient
removal of heat and the rapid activation of the innate
acute wound response in vivo [17]. Nevertheless, the
assessment of collateral tissue damage is an important
aspect of surgical device performance. In future experi-
ments, measurements of collateral damage obtained
through histopathology along with temperature elevation
and thermal spread can be incorporated as response
variables within the optimized test-matrix described
here to provide a more comprehensive analysis of device
performance ex vivo.
Conclusions
From this investigation, it was determined that the
design and implementation of a split-plot experimental
test-matrix provided a mechanism for addressing the
existing technical randomization restrictions in a statisti-
cally meaningful way, while preserving the ability to
examine the potential combinatorial effects of indepen-
dent factors or variables that can be assessed in ex vivo
testing. This type of approach would likely be useful to
a broad spectrum of medical device researchers who
must attempt to recapitulate in vivo conditions, ex vivo.
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